LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 345

Search options

  1. Book: Leukemias

    Faderl, Stefan

    principles and practice of therapy

    2011  

    Author's details ed. by Stefan Faderl
    Language English
    Size IX, 446 S. : Ill., graph. Darst.
    Publisher Wiley-Blackwell
    Publishing place Chichester u.a.
    Publishing country Great Britain
    Document type Book
    Note Includes bibliographical references and index
    HBZ-ID HT016615652
    ISBN 978-1-4051-8235-5 ; 1-4051-8235-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book ; Online: Novel Aspects in Acute Lymphoblastic Leukemia

    Faderl, Stefan

    2011  

    Keywords Oncology
    Size 1 electronic resource (272 pages)
    Publisher IntechOpen
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT021046469
    ISBN 9789535165736 ; 9535165739
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Book ; Online ; E-Book: Acute leukemias

    Faderl, Stefan H. / Kantarjian, Hagop / Estey, Elihu H.

    (Hematologic malignancies)

    2021  

    Author's details Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey editors
    Series title Hematologic malignancies
    Language English
    Size 1 Online-Ressource (vi, 289 Seiten), Illustrationen, Diagramme
    Edition Second edition
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT020618612
    ISBN 978-3-030-53633-6 ; 9783030536329 ; 3-030-53633-5 ; 3030536327
    DOI 10.1007/978-3-030-53633-6
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  4. Book ; Thesis: Durchflußzytometrischer Nachweis von Enzymen der primären Granula zur Immunphänotypisierung akuter myeloischer Leukämien

    Faderl, Stefan

    1994  

    Author's details vorgelegt von Stefan Faderl
    Language German
    Size 76 S. : graph. Darst.
    Document type Book ; Thesis
    Thesis / German Habilitation thesis München, Univ., Diss., 1994
    HBZ-ID HT006576778
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article: A young ALL patient with a long history of treatment: case presentation.

    Faderl, Stefan

    Clinical advances in hematology ; & ; oncology : H ; & ; O

    2014  Volume 12, Issue 12 Suppl 20, Page(s) 17–18

    Language English
    Publishing date 2014-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2271951-9
    ISSN 1543-0790
    ISSN 1543-0790
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.

    Cortes, Jorge E / Lin, Tara L / Asubonteng, Kobby / Faderl, Stefan / Lancet, Jeffrey E / Prebet, Thomas

    Journal of hematology & oncology

    2022  Volume 15, Issue 1, Page(s) 155

    Abstract: CPX-351 (Europe: ... ...

    Abstract CPX-351 (Europe: Vyxeos
    MeSH term(s) Aged ; Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cytarabine/adverse effects ; Daunorubicin/adverse effects ; Leukemia, Myeloid, Acute ; Neoplasms, Second Primary/drug therapy
    Chemical Substances CPX-351 ; Cytarabine (04079A1RDZ) ; Daunorubicin (ZS7284E0ZP)
    Language English
    Publishing date 2022-10-26
    Publishing country England
    Document type Clinical Trial, Phase III ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2429631-4
    ISSN 1756-8722 ; 1756-8722
    ISSN (online) 1756-8722
    ISSN 1756-8722
    DOI 10.1186/s13045-022-01361-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.

    Solomon, Scott R / Powell, Bayard L / Koprivnikar, Jamie / Lai, Catherine / Male, Heather / Michaelis, Laura C / Newell, Laura F / Sanford, David / Jenkins, Jack / Zelaya, Amy / Coppola, Sheryl / Faderl, Stefan / Walter, Roland B

    Cancers

    2024  Volume 16, Issue 5

    Abstract: This open-label phase 1 study (clinicaltrials.gov, NCT03555955) assessed CPX-351 pharmacokinetics (PK) and safety in patients with hematologic malignancies with normal or impaired renal function. Patients were enrolled into three cohorts based on their ... ...

    Abstract This open-label phase 1 study (clinicaltrials.gov, NCT03555955) assessed CPX-351 pharmacokinetics (PK) and safety in patients with hematologic malignancies with normal or impaired renal function. Patients were enrolled into three cohorts based on their creatinine clearance (CrCl): ≥90 mL/min (Cohort 1, normal renal function,
    Language English
    Publishing date 2024-02-24
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16050915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Last exit clofarabine?

    Faderl, Stefan

    Leukemia & lymphoma

    2009  Volume 50, Issue 12, Page(s) 1907–1908

    MeSH term(s) Acute Disease ; Adenine Nucleotides/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Arabinonucleosides/administration & dosage ; Clofarabine ; Cyclophosphamide/administration & dosage ; Cytarabine/administration & dosage ; Humans ; Leukemia/drug therapy ; Leukemia/pathology ; Leukemia/surgery ; Leukemia, Myeloid/drug therapy ; Leukemia, Myeloid/pathology ; Leukemia, Myeloid/surgery ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery ; Salvage Therapy/methods ; Stem Cell Transplantation/methods ; Transplantation, Homologous ; Treatment Outcome
    Chemical Substances Adenine Nucleotides ; Arabinonucleosides ; Cytarabine (04079A1RDZ) ; Clofarabine (762RDY0Y2H) ; Cyclophosphamide (8N3DW7272P)
    Language English
    Publishing date 2009-11-12
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.3109/10428190903350447
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.

    Uy, Geoffrey L / Newell, Laura F / Lin, Tara L / Goldberg, Stuart L / Wieduwilt, Matthew J / Ryan, Robert J / Faderl, Stefan / Lancet, Jeffrey E

    Blood advances

    2022  Volume 6, Issue 17, Page(s) 4989–4993

    MeSH term(s) Aged ; Cytarabine ; Daunorubicin ; Humans ; Leukemia, Myeloid, Acute/therapy ; Neoplasms, Second Primary
    Chemical Substances CPX-351 ; Cytarabine (04079A1RDZ) ; Daunorubicin (ZS7284E0ZP)
    Language English
    Publishing date 2022-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2021006468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.

    Skarbnik, Alan P / Faderl, Stefan

    Therapeutic advances in hematology

    2016  Volume 8, Issue 3, Page(s) 99–105

    Abstract: Chemoimmunotherapy (CIT) has become a cornerstone in the treatment of patients with chronic lymphocytic leukemia (CLL). The combination of fludarabine, cyclophosphamide and rituximab (FCR) has emerged as the standard of care for therapy of previously ... ...

    Abstract Chemoimmunotherapy (CIT) has become a cornerstone in the treatment of patients with chronic lymphocytic leukemia (CLL). The combination of fludarabine, cyclophosphamide and rituximab (FCR) has emerged as the standard of care for therapy of previously untreated patients with CLL who are younger than 65 years and have no significant comorbidities. In this article, we review the role of FCR in the current treatment paradigm for CLL.
    Language English
    Publishing date 2016-12-01
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2585183-4
    ISSN 2040-6215 ; 2040-6207
    ISSN (online) 2040-6215
    ISSN 2040-6207
    DOI 10.1177/2040620716681749
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top